Barcelona Health Hub welcomed Ana Zubeldia Masset, Business Unit Head Oncology Spain of Daiichi Sankyo, at the BHH Headquarters. She met with BHH’s Chief Communications Officer Marja Huiskamp to talk about the future plans for this Japanese pharmaceutical company in this #BHHInterview.
Ana explains that at Daiichi Sankyo in the oncology department, it’s a very big moment, since the research area is taking a leap forward. They focus on new technologies and investigations to add value for different types of tumors. She also explainds that the company aims to be an intergal partner to all stakeholders in the ecosystem, since startups are becoming more and more essential to move forward in digital health. “Together we can add value in innovation,” she adds.